IHS Chemical Week

Markets :: Specialty Chemicals :: Biocides

Lonza Completes Arch Deal; Lists on Singapore Stock Exchange

9:51 AM MDT | October 20, 2011 | Kerri Walsh

Lonza has completed its acquisition of Arch Chemicals for $1.4 billion, or $47.20/share. Lonza says it owns more than 90% of Arch’s outstanding shares, and expects to complete the deal through a short-form merger no later than October 21. Upon completion of the merger, Arch will become an indirect, wholly-owned subsidiary of Lonza.   The acquisition creates the largest biocides business, and expands Lonza’s non-pharma life science business, says Lonza CEO Stefan Borgas. “After having built the world's leading pharmaceutical contract...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa